A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer ; volume:13 ; number:1 ; day:30 ; month:6 ; year:2021 ; pages:1-15 ; date:12.2021
Clinical epigenetics ; 13, Heft 1 (30.6.2021), 1-15, 12.2021
- Creator
-
Ylitalo, Erik Bovinder
Thysell, Elin
Landfors, Mattias
Brattsand, Maria
Jernberg, Emma
Crnalic, Sead
Widmark, Anders
Hultdin, Magnus
Bergh, Anders
Degerman, Sofie
Wikström, Pernilla
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13148-021-01119-0
- URN
-
urn:nbn:de:101:1-2021101219492712048103
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ylitalo, Erik Bovinder
- Thysell, Elin
- Landfors, Mattias
- Brattsand, Maria
- Jernberg, Emma
- Crnalic, Sead
- Widmark, Anders
- Hultdin, Magnus
- Bergh, Anders
- Degerman, Sofie
- Wikström, Pernilla
- SpringerLink (Online service)
Other Objects (12)
Androgen receptor and osteoglycin gene expression predicting prognosis of metastatic prostate cancer
Cuproptosis-related DNA methylation signature predict prognosis and immune microenvironment in cutaneous melanoma
Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis
An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer
Development of a Signature Based on Eight Metastatic-Related Genes for Prognosis of GC Patients
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
Androgen deficiency is associated with a better prognosis in glioblastoma
Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation
Androgen receptor and osteoglycin gene expression predicting prognosis of metastatic prostate cancer
Cuproptosis-related DNA methylation signature predict prognosis and immune microenvironment in cutaneous melanoma
Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis
An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer
Development of a Signature Based on Eight Metastatic-Related Genes for Prognosis of GC Patients
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
Androgen deficiency is associated with a better prognosis in glioblastoma
Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma
Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation
Androgen receptor and osteoglycin gene expression predicting prognosis of metastatic prostate cancer
Cuproptosis-related DNA methylation signature predict prognosis and immune microenvironment in cutaneous melanoma
Immunogenic profiling of metastatic uveal melanoma discerns a potential signature related to prognosis
An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer
Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer
Development of a Signature Based on Eight Metastatic-Related Genes for Prognosis of GC Patients
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
Androgen deficiency is associated with a better prognosis in glioblastoma
Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma
Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma